SCHEMBL4733892

SCHEMBL4733892

CC(C)Oc1ccc(C#Cc2ccccc2OCC#N)cc1C(=O)N[C@@H](CO)Cc1c[nH]c2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 6/20 0.40
HDAC1 Q13547 6/20 0.40
HDAC2 Q92769 6/20 0.40
HDAC4 P56524 5/20 0.40
HDAC7 Q8WUI4 5/20 0.40
HDAC10 Q969S8 5/20 0.40
HDAC11 Q96DB2 5/20 0.40
HDAC8 Q9BY41 5/20 0.40
HDAC6 Q9UBN7 5/20 0.40
HDAC9 Q9UKV0 5/20 0.40
HDAC5 Q9UQL6 5/20 0.40
CTSL P07711 2/20 0.39
CTSC P53634 1/20 0.38
FFAR1 O14842 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CYP2D6 P10635 2/20 0.38
SLC22A1 O15245 1/20 0.38
TACR1 P25103 5/20 0.38
CTSS P25774 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14162030 0.91 HDAC3 (0.41) HDAC3HDAC1HDAC2HDAC4HDAC7
SCHEMBL4633717 0.91 HDAC3 (0.44) HDAC3HDAC1HDAC2HDAC4HDAC7
SCHEMBL4632690 0.91 HDAC3 (0.44) HDAC3HDAC1HDAC2HDAC4HDAC7
SCHEMBL4633753 0.90 CTSC (0.41) HDAC3HDAC1HDAC2HDAC4HDAC7
SCHEMBL4634729 0.89 MEN1 (0.41) HDAC3HDAC1HDAC2HDAC4HDAC7
SCHEMBL14070036 0.88 CTSL (0.41) HDAC3HDAC1HDAC2HDAC4HDAC7
SCHEMBL4633411 0.88 HDAC3 (0.43) HDAC3HDAC1HDAC2HDAC4HDAC7
SCHEMBL4736574 0.88 CDK2 (0.43) HDAC3HDAC1HDAC2HDAC4HDAC7
SCHEMBL4633755 0.87 ITGB2 (0.43) HDAC3HDAC1HDAC2HDAC4HDAC7
SCHEMBL4632734 0.87 ACACB (0.42) HDAC3HDAC1HDAC2HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221195-A1 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-09-11 US claimed
WO-2008071453-A1 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-06-19 WO claimed
US-20080221195-A1 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-09-11 US disclosed
WO-2008071453-A1 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221195-A1 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS FSHR, GNRHR, TPH1 HDAC3 1526/4885HDAC1 1780/4885HDAC2 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.